<VariationArchive VariationID="1699116" VariationName="NM_001904.4(CTNNB1):c.1350dup (p.Val451fs)" VariationType="Duplication" Accession="VCV001699116" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-23" DateCreated="2022-08-08" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1691490" VariationID="1699116">
      <GeneList>
        <Gene Symbol="LOC126806659" FullName="BRD4-independent group 4 enhancer GRCh37_chr3:41274918-41276117" GeneID="126806659" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41233427" stop="41234626" display_start="41233427" display_stop="41234626" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="CTNNB1" FullName="catenin beta 1" GeneID="1499" HGNC_ID="HGNC:2514" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41199505" stop="41240443" display_start="41199505" display_stop="41240443" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="41240941" stop="41281938" display_start="41240941" display_stop="41281938" Strand="+" />
          </Location>
          <OMIM>116806</OMIM>
          <Haploinsufficiency last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CTNNB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CTNNB1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001904.4(CTNNB1):c.1350dup (p.Val451fs)</Name>
      <CanonicalSPDI>NC_000003.12:41233692:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41233692" stop="41233693" display_start="41233692" display_stop="41233693" variantLength="1" positionVCF="41233692" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="41275183" stop="41275184" display_start="41275183" display_stop="41275184" variantLength="1" positionVCF="41275183" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>V444fs</ProteinChange>
      <ProteinChange>V451fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.41275184dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.41275184dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.41233693dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.41233693dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013302.2" sequenceAccession="NG_013302" sequenceVersion="2" change="g.39243dup">
            <Expression>NG_013302.2:g.39243dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098209.2" sequenceAccession="NM_001098209" sequenceVersion="2" change="c.1350dup">
            <Expression>NM_001098209.2:c.1350dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001091679.1" sequenceAccession="NP_001091679" sequenceVersion="1" change="p.Val451fs">
            <Expression>NP_001091679.1:p.Val451fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098210.2" sequenceAccession="NM_001098210" sequenceVersion="2" change="c.1350dup">
            <Expression>NM_001098210.2:c.1350dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001091680.1" sequenceAccession="NP_001091680" sequenceVersion="1" change="p.Val451fs">
            <Expression>NP_001091680.1:p.Val451fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330729.2" sequenceAccession="NM_001330729" sequenceVersion="2" change="c.1329dup">
            <Expression>NM_001330729.2:c.1329dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317658.1" sequenceAccession="NP_001317658" sequenceVersion="1" change="p.Val444fs">
            <Expression>NP_001317658.1:p.Val444fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001904.4" sequenceAccession="NM_001904" sequenceVersion="4" change="c.1350dup" MANESelect="true">
            <Expression>NM_001904.4:c.1350dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001895.1" sequenceAccession="NP_001895" sequenceVersion="1" change="p.Val451fs">
            <Expression>NP_001895.1:p.Val451fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1108" sequenceAccession="LRG_1108">
            <Expression>LRG_1108:g.39243dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1108t1" sequenceAccession="LRG_1108t1">
            <Expression>LRG_1108t1:c.1350dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1108p1" sequenceAccession="LRG_1108p1" change="p.Val451fs">
            <Expression>LRG_1108p1:p.Val451fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2125639718" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001904.4(CTNNB1):c.1350dup (p.Val451fs) AND Severe intellectual disability-progressive spastic diplegia syndrome" Accession="RCV002272973" Version="3">
        <ClassifiedConditionList TraitSetID="9236">
          <ClassifiedCondition DB="MedGen" ID="C3554449">Severe intellectual disability-progressive spastic diplegia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-08" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">35099645</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9236" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17594" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Severe intellectual disability-progressive spastic diplegia syndrome</ElementValue>
                <XRef ID="MONDO:0014035" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS</ElementValue>
                <XRef Type="MIM" ID="615075" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0022" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEDSDV</ElementValue>
                <XRef Type="MIM" ID="615075" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3505" />
                <XRef ID="3505" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CTNNB1 neurodevelopmental disorder (CTNNB1-NDD) is characterized in all individuals by mild-to-profound cognitive impairment and in up to 39% of reported individuals by exudative vitreoretinopathy, an ophthalmologic finding consistent with familial exudative vitreoretinopathy (FEVR). Other common findings include truncal hypotonia, peripheral spasticity, dystonia, behavior problems, microcephaly, and refractive errors and strabismus. Less common features include intrauterine growth restriction, feeding difficulties, and scoliosis.</Attribute>
                <XRef ID="NBK580527" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35593792</ID>
                <ID Source="BookShelf">NBK580527</ID>
              </Citation>
              <XRef ID="404473" DB="Orphanet" />
              <XRef ID="C3554449" DB="MedGen" />
              <XRef ID="MONDO:0014035" DB="MONDO" />
              <XRef Type="MIM" ID="615075" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5003285" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001904_3_CTNNB1_c_1350dupT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557479" DateUpdated="2024-07-23" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">35099645</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with neurodevelopmental disorder with spastic diplegia and visual defects (MIM#615075), and exudative vitreoretinopathy 7 (MIM#617572). However, somatic variants with a gain of function mechanism have been reported to cause cancer (OMIM). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. These variants have been reported many times as pathogenic (PMID: 35099645, DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed, by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNNB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_14631</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001904.3:c.1350dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615075" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5003285" TraitType="Disease" MappingType="XRef" MappingValue="615075" MappingRef="OMIM">
        <MedGen CUI="C3554449" Name="Severe intellectual disability-progressive spastic diplegia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

